KROS Company Profile and Key Details

Q: Who are the executives of KROS?

Mr. John Oram M.B.A.Senior Vice President of Program & Portfolio ManagementDr. Simon Cooper MBBSChief Medical OfficerMs. Esther Cho J.D.Senior Vice President, Gen. Counsel & Sec.Dr. Jasbir S. Seehra Ph.D.Pres, Chief Executive Officer, Treasurer, & DirectorMr. Christopher Rovaldi M.Sc.Chief Operating OfficerMr. John OramSenior Vice President of Program & Portfolio ManagementMr. Keith C. Regnante MBAChief Financial OfficerMs. Robin WagnerVice President of HRDr. Jennifer Lachey Ph.D.Chief Scientific Officer

NASDAQ : KROS

Keros Therapeutics

$12.07

0.43+3.69%

At Close 4:00 PM

60.34

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Keros Therapeutics, Inc. (KROS) stock surged +3.69%, trading at $12.07 on NASDAQ, up from the previous close of $11.64. The stock opened at $11.39, fluctuating between $11.38 and $12.11 in the recent session.

Stock Snapshot

11.64

Prev. Close

449.26M

Market Cap

11.375

Day Low

5.25

P/E Ratio

2.3

EPS (TTM)

-4.21

Cash Flow per Share

11.39

Open

37.22M

Number of Shares

12.109

Day High

83.47%

Free Float in %

11.03

Book Value

393.1K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 08, 2026	11.60	12.10	11.38	12.07	393.1K
May 07, 2026	11.73	11.74	11.35	11.64	157.11K
May 06, 2026	11.84	11.95	11.59	11.78	304.77K
May 05, 2026	11.75	11.84	11.45	11.77	309.65K
May 04, 2026	11.41	12.07	11.41	11.71	392.04K
Apr 30, 2026	11.04	11.19	10.88	11.12	266.36K
Apr 29, 2026	11.19	11.23	10.95	11.10	209.69K
Apr 28, 2026	11.04	11.49	11.04	11.37	269.07K
Apr 27, 2026	11.44	11.69	10.98	11.01	381.55K
Apr 23, 2026	11.43	11.58	11.40	11.56	252.59K
Apr 22, 2026	11.33	11.51	11.33	11.44	183.62K
Apr 21, 2026	11.55	11.58	11.25	11.31	293.1K
Apr 20, 2026	11.72	11.84	11.60	11.66	225.79K
Apr 17, 2026	11.98	12.00	11.57	11.67	371.52K
Apr 16, 2026	11.69	11.75	11.55	11.72	221.72K
Apr 14, 2026	11.18	11.61	11.17	11.55	307.23K
Apr 13, 2026	11.20	11.33	10.78	11.15	469.6K
Apr 10, 2026	12.46	12.47	11.20	11.21	333.89K
Apr 09, 2026	12.29	12.63	12.18	12.49	336.97K
Apr 08, 2026	12.63	12.65	12.32	12.55	349.9K

Contact Details

Lexington, MA 02421

United States

https://www.kerostx.com 617 314 6297

About Company

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Stock Peers

ARGX

-5.14-0.65%

argenx SE$782.17 REGN

5.79+0.82%

Regeneron Pharmaceuticals, Inc.$714.89 UTHR

-4.24-0.74%

United Therapeutics Corporation$564.94 MDGL

-24.82-4.64%

Madrigal Pharmaceuticals, Inc.$510.04 VRTX

4.82+1.13%

Vertex Pharmaceuticals Incorporated$429.82 PRAX

-3.26-0.98%

Praxis Precision Medicines, Inc.$330.02 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

9.01+3.04%

Krystal Biotech, Inc.$305.71 ALNY

-0.86-0.29%

Alnylam Pharmaceuticals, Inc.$295.05 ASND

-7.48-3.04%

Ascendis Pharma A/S$238.66

Frequently Asked Questions

What is the current Keros Therapeutics, Inc. (KROS) stock price?

Keros Therapeutics, Inc. (NASDAQ: KROS) stock price is $12.07 in the last trading session. During the trading session, KROS stock reached the peak price of $12.11 while $11.38 was the lowest point it dropped to. The percentage change in KROS stock occurred in the recent session was 3.69% while the dollar amount for the price change in KROS stock was $0.43.

KROS's industry and sector of operation?

The NASDAQ listed KROS is part of Biotechnology industry that operates in the broader Healthcare sector. Keros Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KROS?

Mr. John Oram M.B.A.
Senior Vice President of Program & Portfolio Management
Dr. Simon Cooper MBBS
Chief Medical Officer
Ms. Esther Cho J.D.
Senior Vice President, Gen. Counsel & Sec.
Dr. Jasbir S. Seehra Ph.D.
Pres, Chief Executive Officer, Treasurer, & Director
Mr. Christopher Rovaldi M.Sc.
Chief Operating Officer
Mr. John Oram
Senior Vice President of Program & Portfolio Management
Mr. Keith C. Regnante MBA
Chief Financial Officer
Ms. Robin Wagner
Vice President of HR
Dr. Jennifer Lachey Ph.D.
Chief Scientific Officer

How KROS did perform over past 52-week?

KROS's closing price is 15.89% higher than its 52-week low of $10.42 where as its distance from 52-week high of $22.55 is -46.48%.

How many employees does KROS have?

Number of KROS employees currently stands at 163.

Link for KROS official website?

Official Website of KROS is: https://www.kerostx.com

How do I contact KROS?

KROS could be contacted at phone 617 314 6297 and can also be accessed through its website. KROS operates from 99 Hayden Avenue, Lexington, MA 02421, United States.

How many shares of KROS are traded daily?

KROS stock volume for the day was 393.1K shares. The average number of KROS shares traded daily for last 3 months was 412.27K.

What is the market cap of KROS currently?

The market value of KROS currently stands at $449.26M with its latest stock price at $12.07 and 37.22M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	163
Beta	0.9
Sales or Revenue	$151.00K
5Y Sales Change%	-0.995%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	163
Beta	0.9
Sales or Revenue	$151.00K
5Y Sales Change%	-0.995%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KROS Company Profile and Key Details

Keros Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook